Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P13
Within normal range
vs 3Y Ago
-2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.66% |
| Q3 2025 | 6.79% |
| Q2 2025 | 23.67% |
| Q1 2025 | -13.57% |
| Q4 2024 | -0.36% |
| Q3 2024 | 11.45% |
| Q2 2024 | 11.57% |
| Q1 2024 | 8.42% |
| Q4 2023 | 9.55% |
| Q3 2023 | 5.00% |
| Q2 2023 | 11.42% |
| Q1 2023 | 2.52% |
| Q4 2022 | 1.31% |
| Q3 2022 | -1.60% |
| Q2 2022 | 10.35% |
| Q1 2022 | -5.20% |
| Q4 2021 | 2.80% |
| Q3 2021 | 4.96% |
| Q2 2021 | 15.30% |
| Q1 2021 | -7.35% |
| Q4 2020 | -0.69% |
| Q3 2020 | -2.53% |
| Q2 2020 | -5.02% |
| Q1 2020 | 6.09% |
| Q4 2019 | 7.84% |
| Q3 2019 | 12.80% |
| Q2 2019 | 11.46% |
| Q1 2019 | -3.00% |
| Q4 2018 | 3.70% |
| Q3 2018 | 3.42% |
| Q2 2018 | 8.07% |
| Q1 2018 | 8.22% |
| Q4 2017 | 24.59% |
| Q3 2017 | 20.26% |
| Q2 2017 | 28.84% |
| Q1 2017 | 15.90% |
| Q4 2016 | 9.61% |
| Q3 2016 | 10.15% |
| Q2 2016 | 22.81% |
| Q1 2016 | 7.31% |